Social Anxiety Disorder (SAD/Social Phobia) – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Social Anxiety Disorder (SAD/Social Phobia) – Drugs In Development, 2024 report and make more profitable business decisions.
Social anxiety disorder (SAD), also known as social phobia, is an anxiety disorder characterized by sentiments of fear and anxiety in social situations, causing considerable distress and impairing ability to function in at least some aspects of daily life. These fears can be triggered by perceived or actual scrutiny from others.
The Social Anxiety Disorder (SAD/Social Phobia) drugs in development market research report provide comprehensive information on the therapeutics under development for Social Anxiety Disorder (SAD/Social Phobia), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Social Anxiety Disorder (SAD/Social Phobia) and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Social Anxiety Disorder (SAD/Social Phobia) | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 15 molecules, with 15 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Social Anxiety Disorder (SAD/Social Phobia) therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Social Anxiety Disorder (SAD/Social Phobia) pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Social Anxiety Disorder (SAD/Social Phobia) treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
AffaMed Therapeutics US IncAnanda Scientific Inc
Bionomics Ltd
Boehringer Ingelheim International GmbH
Cybin Inc
EmpowerPharm Inc
Exxel Pharma Inc
F. Hoffmann-La Roche Ltd
GABA Therapeutics Inc
Mind Medicine MindMed Inc
PharmAla Biotech Inc
PSYLO Pty Ltd
Receptor Life Sciences Inc
Tonix Pharmaceuticals Holding Corp
Vanda Pharmaceuticals Inc
VistaGen Therapeutics Inc
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Social Anxiety Disorder (SAD/Social Phobia) reports